RTTNews | Jan 13, 2021 07:13AM EST

07:12 Wednesday, January 13, 2021 (RTTNews) - Glaukos Says IDose TR Demonstrates Sustained IOP Reduction And Favorable Safety Profile Over 24 Months In Phase 2b Study

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved